Compare GPK & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPK | LNTH |
|---|---|---|
| Founded | 2007 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.4B |
| IPO Year | 1992 | 2015 |
| Metric | GPK | LNTH |
|---|---|---|
| Price | $15.38 | $66.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $19.86 | ★ $77.33 |
| AVG Volume (30 Days) | ★ 5.3M | 1.0M |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.82% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.70 | ★ 2.39 |
| Revenue | ★ $8,609,000,000.00 | $1,525,933,000.00 |
| Revenue This Year | N/A | $0.01 |
| Revenue Next Year | $0.21 | $1.24 |
| P/E Ratio | ★ $9.17 | $27.84 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $13.93 | $47.25 |
| 52 Week High | $29.90 | $111.29 |
| Indicator | GPK | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 71.07 |
| Support Level | $13.93 | $60.15 |
| Resistance Level | $15.59 | $64.40 |
| Average True Range (ATR) | 0.48 | 2.02 |
| MACD | 0.02 | 0.72 |
| Stochastic Oscillator | 55.41 | 89.69 |
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.